Lupin Ltd gets 7 observations from USFDA for Goa facility

Lupin Ltd has announced that the U.S. FDA has concluded an inspection at our Goa facility in India. The inspection was carried out from September 6, 2021 to September 18, 2021 and closed with seven observations.

The company is confident of addressing the observations satisfactorily and are committed to be compliant with Good Manufacturing Practice standards across all our facilities.

Shares of Lupin Ltd was last trading in BSE at Rs. 950.15 as compared to the previous close of Rs. 967.7. The total number of shares traded during the day was 93619 in over 4897 trades.

The stock hit an intraday high of Rs. 966.95 and intraday low of 943.95. The net turnover during the day was Rs. 89238583.

Source : Equity Bulls

Keywords